Evidence map›Paper›PMID 24850790›Full record

ArticleThe Journal of infectious diseases2015

Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challenge.

Sandeep Gupta, Poonam Pegu, David J Venzon, Johannes S Gach, Zhong-Min Ma, Gary Landucci, Christopher J Miller, Genoveffa Franchini, Donald N Forthal

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Analysis of BeyfortusCurrent issues in molecular biology · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Sandeep GuptaDivision of Infectious Diseases, Department of Medicine, University of California, Irvine School of Medicine, Irvine.
Poonam PeguAnimal Models and Retroviral Vaccine Section.
David J VenzonBiostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Johannes S GachDivision of Infectious Diseases, Department of Medicine, University of California, Irvine School of Medicine, Irvine.
Zhong-Min MaCenter for Comparative Medicine.
Gary LanducciDivision of Infectious Diseases, Department of Medicine, University of California, Irvine School of Medicine, Irvine.
Christopher J MillerCenter for Comparative Medicine Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis.
Genoveffa FranchiniAnimal Models and Retroviral Vaccine Section.
Donald N ForthalDivision of Infectious Diseases, Department of Medicine, University of California, Irvine School of Medicine, Irvine.
Institut de Recherche Vaccinale · FRNational Cancer Institute · USUniversity of California, Davis · US

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Preventive Vaccines for HIVZIABC011126 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI FRANCHINI, GENOVEFFA · 2009 to 2025
$55.3M
Office of Collaborative BiostatisticsZIDSC007202 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI CHOO-WOSOBA, HYOYOUNG · 2009 to 2025
$14.5M
The impact of antibody and pH on female-to-male SIV infectionR01AI102715 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI FORTHAL, DONALD N, MILLER, CHRISTOPHER JAMES · 2012 to 2015
$2.7M
Intramural NIH HHSNIAID NIH HHS AI102715NIAID NIH HHS R01 AI102715NIH HHS P51 OD011107PHS HHS HHSN2662004000088C
6 · The paper itself

Abstract

backgroundThe time to acquisition of simian immunodeficiency virus (SIV) infection following low-dose repeated rectal challenge correlated inversely with the number of transmitted/founder strains among macaques vaccinated with ALVAC-SIV/gp120 or gp120 alone. We determined if the ability of postvaccination, prechallenge sera to enhance SIVmac251 transcytosis across epithelial cells was associated with transmitted/founder strain number.

methodsTranscytosis was carried out by exposing sera and SIVmac251 to the apical surface of human endometrial carcinoma (HEC-1A) cells at pH 6.0 and 12 hours later quantifying virus in fluid bathing the basolateral cell surface (maintained at pH 7.4). These conditions allow Fc neonatal receptor (FcRn)-dependent shuttling of virus across cells.

resultsThere was a strong correlation between the amount of virus transcytosed and number of transmitted variants (R = 0.86, P < .0001). We also found that 4 animals who remained uninfected after repeated rectal challenges had lower serum transcytosis activity than did 19 animals who subsequently became infected (P = .003). Using immunohistochemistry, we demonstrated FcRn on columnar epithelial cells facing the lumen of the macaque rectum.

conclusionsVaccine-induced antibody capable of enhancing transcytosis in vitro via FcRn may play a role in determining transmitted/founder strain number and infection outcomes following in vivo challenge.

Indexed as

AnimalsAntibodiesCell Line, TumorEndometrial NeoplasmsEpithelial CellsFemaleHistocompatibility Antigens Class IHumansMacaca mulattaMaleReceptors, FcRectumSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusTranscytosisViral VaccinesAntibodiesFc receptor, neonatalHistocompatibility Antigens Class IReceptors, FcViral VaccinesantibodyFc neonatal receptorSIVtranscytosisvaccine

Identifiers

PMID24850790
PMCPMC4334821
OpenAlexW2143259658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.